248 related articles for article (PubMed ID: 34307658)
21. Methods for Measuring ctDNA in Lymphomas.
Rossi D; Condoluci A; Spina V; Gaidano G
Methods Mol Biol; 2019; 1881():253-265. PubMed ID: 30350211
[TBL] [Abstract][Full Text] [Related]
22. Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC).
Sherwood JL; Corcoran C; Brown H; Sharpe AD; Musilova M; Kohlmann A
PLoS One; 2016; 11(2):e0150197. PubMed ID: 26918901
[TBL] [Abstract][Full Text] [Related]
23. Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients.
Risberg B; Tsui DWY; Biggs H; Ruiz-Valdepenas Martin de Almagro A; Dawson SJ; Hodgkin C; Jones L; Parkinson C; Piskorz A; Marass F; Chandrananda D; Moore E; Morris J; Plagnol V; Rosenfeld N; Caldas C; Brenton JD; Gale D
J Mol Diagn; 2018 Nov; 20(6):883-892. PubMed ID: 30165204
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing.
Alidousty C; Brandes D; Heydt C; Wagener S; Wittersheim M; Schäfer SC; Holz B; Merkelbach-Bruse S; Büttner R; Fassunke J; Schultheis AM
J Mol Diagn; 2017 Sep; 19(5):801-804. PubMed ID: 28732213
[TBL] [Abstract][Full Text] [Related]
25. Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology.
Diaz IM; Nocon A; Held SAE; Kobilay M; Skowasch D; Bronkhorst AJ; Ungerer V; Fredebohm J; Diehl F; Holdenrieder S; Holtrup F
Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046506
[TBL] [Abstract][Full Text] [Related]
26. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction.
Lee JS; Kim M; Seong MW; Kim HS; Lee YK; Kang HJ
Clin Chem Lab Med; 2020 Mar; 58(4):527-532. PubMed ID: 31874093
[TBL] [Abstract][Full Text] [Related]
27. Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood.
Jain M; Balatsky AV; Revina DB; Samokhodskaya LM
Mol Cell Probes; 2019 Feb; 43():13-19. PubMed ID: 30584912
[TBL] [Abstract][Full Text] [Related]
28. Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA.
Gawroński AR; Lin YY; McConeghy B; LeBihan S; Asghari H; Koçkan C; Orabi B; Adra N; Pili R; Collins CC; Sahinalp SC; Hach F
Nucleic Acids Res; 2019 Apr; 47(7):e38. PubMed ID: 30759232
[TBL] [Abstract][Full Text] [Related]
29. Effects of Quantification Methods, Isolation Kits, Plasma Biobanking, and Hemolysis on Cell-Free DNA Analysis in Plasma.
Streleckiene G; Forster M; Inciuraite R; Lukosevicius R; Skieceviciene J
Biopreserv Biobank; 2019 Dec; 17(6):553-561. PubMed ID: 31343271
[TBL] [Abstract][Full Text] [Related]
30. Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Soscia R; Della Starza I; De Novi LA; Ilari C; Ansuinelli M; Cavalli M; Bellomarino V; Cafforio L; Di Trani M; Cazzaniga G; Fazio G; Santoro A; Salemi D; Spinelli O; Tosi M; Terragna C; Robustelli V; Bellissimo T; Colafigli G; Breccia M; Chiaretti S; Di Rocco A; Martelli M; Guarini A; Del Giudice I; Foà R
Hematol Oncol; 2023 Feb; 41(1):50-60. PubMed ID: 36251440
[TBL] [Abstract][Full Text] [Related]
31. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
[TBL] [Abstract][Full Text] [Related]
32. "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.
Murray MJ; Watson HL; Ward D; Bailey S; Ferraresso M; Nicholson JC; Gnanapragasam VJ; Thomas B; Scarpini CG; Coleman N
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):208-218. PubMed ID: 29254935
[No Abstract] [Full Text] [Related]
33. Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review.
Arzuaga-Mendez J; Prieto-Fernández E; Lopez-Lopez E; Martin-Guerrero I; García-Ruiz JC; García-Orad A
Crit Rev Oncol Hematol; 2019 Jul; 139():7-15. PubMed ID: 31112884
[TBL] [Abstract][Full Text] [Related]
34. Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics.
Takahashi G; Yamada T; Iwai T; Takeda K; Koizumi M; Shinji S; Uchida E
Ann Surg Oncol; 2018 Mar; 25(3):737-744. PubMed ID: 29235008
[TBL] [Abstract][Full Text] [Related]
35. The relevance of tumor mutation profiling in interpretation of NGS data from cell-free DNA in non-small cell lung cancer patients.
Ottestad AL; Wahl SGF; Grønberg BH; Skorpen F; Dai HY
Exp Mol Pathol; 2020 Feb; 112():104347. PubMed ID: 31759951
[TBL] [Abstract][Full Text] [Related]
36. Effects of blood-processing protocols on cell-free DNA fragmentomics in plasma: Comparisons of one- and two-step centrifugations.
Hu X; Zhang H; Wang Y; Lin Y; Li Q; Li L; Zeng G; Ou R; Cheng X; Zhang Y; Jin X
Clin Chim Acta; 2024 Jun; 560():119729. PubMed ID: 38754575
[TBL] [Abstract][Full Text] [Related]
37. Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study.
Rivas-Delgado A; Nadeu F; Enjuanes A; Casanueva-Eliceiry S; Mozas P; Magnano L; Castrejón de Anta N; Rovira J; Dlouhy I; Martín S; Osuna M; Rodríguez S; Simó M; Pinyol M; Baumann T; Beà S; Balagué O; Delgado J; Villamor N; Setoain X; Campo E; Giné E; López-Guillermo A
Clin Cancer Res; 2021 Jan; 27(2):513-521. PubMed ID: 33122345
[TBL] [Abstract][Full Text] [Related]
38. Performance of ImproGene Cell-Free DNA Tubes for Stabilization and Analysis of cfDNA in Blood Samples.
Luo J; Wang S; Zhang S; He Y; Li S; Han J; Xu M; Deng G
Fetal Pediatr Pathol; 2022 Oct; 41(5):771-780. PubMed ID: 34547970
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma.
Wu FT; Lu L; Xu W; Li JY
Ann Hematol; 2019 Feb; 98(2):255-269. PubMed ID: 30368587
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of circulating tumor DNA stability In K
Kang Q; Henry NL; Paoletti C; Jiang H; Vats P; Chinnaiyan AM; Hayes DF; Merajver SD; Rae JM; Tewari M
Clin Biochem; 2016 Dec; 49(18):1354-1360. PubMed ID: 27129799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
